circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling.
Shengchao XuChengke LuoDikang ChenLu TangQuan ChengLing ChenZhixiong LiuPublished in: Journal of experimental & clinical cancer research : CR (2023)
Our study revealed a novel mechanism of TTF that TTF-mediated reduction of circMMD could inhibit Wnt/β-catenin pathway to suppress GBM proliferation.